
Indo US Bio-Tech Ltd is Rated Sell
2026-07-27 10:10:31Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
Markets Rally, But Indo US Bio-Tech Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-07-27 09:56:44While the Sensex advanced by 0.77% today, Indo US Bio-Tech Ltd slipped to a fresh 52-week low of Rs 84.83, marking a near 50% decline over the past year. This divergence highlights the stock’s ongoing struggles amid broader market strength.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-07-16 10:10:29Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-07-05 10:10:19Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Indo US Bio-Tech Ltd Falls to 52-Week Low of Rs 86 as Sell-Off Deepens
2026-06-30 15:39:13A sharp decline in Indo US Bio-Tech Ltd has pushed the stock to a fresh 52-week low of Rs 86 on 30 Jun 2026, marking a significant 58% drop from its 52-week high of Rs 205.1. This downturn comes amid a backdrop of weakening quarterly financials and diminishing promoter confidence, even as the broader agricultural sector has shown resilience.
Read full news article
Indo US Bio-Tech Ltd is Rated Sell
2026-06-24 10:10:25Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleRevised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015. Ref.: Mail From Query.Lodr@Bseindia.Com On 13.07.2026 Subject: Resignation Of Statutory Auditor And Appointment Of New Statutory Aud
15-Jul-2026 | Source : BSERevised announcement submit.
Revised Outcome Of The Board Meeting Held On 10 July 2026. Reconstitution Of Committees.
15-Jul-2026 | Source : BSECommittee Composition approved in the Outcome of Board Meeting dated 10th July 2026 shall be read as effective from 21st April 2026 being the effective date of the Appointment and resignation of the concerned Directors. Mrs. Neha Patel resigned and Mrs. Hemanshi Darsh Soni is appointed in the meeting of Board of Directors held on 21st April 2026.
Board Meeting Outcome for Change In Composition Of Committees Of The Board. Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
10-Jul-2026 | Source : BSEPursuant to the resignation of Mrs. Nehaben Patel (DIN: 09263180) from the office of Non-Executive Independent Director of the Company the Board of Directors at its meeting held on 21st April 2026 appointed Mrs. Hemanshi Darsh Soni (DIN: 11659183) as an Additional Director (Non-Executive Independent) of the Company subject to the approval of the shareholders. Consequently the Board of Directors of the Company at its meeting held on Friday July 10 2026 has approved the reconstitution of the composition of the aforesaid Committees of the Board with effect from 10th July 2026 in order to ensure compliance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and the Companies Act 2013 wherever applicable. The Board Meeting commenced at 15.00 P.M. and concluded at 15:30 P.M. Please take the same on your record and oblige.
Corporate Actions
No Upcoming Board Meetings
Indo US Bio-Tech Ltd has declared 2% dividend, ex-date: 03 Dec 24
No Splits history available
Indo US Bio-Tech Ltd has announced 1:1 bonus issue, ex-date: 29 Aug 23
No Rights history available









